Balyasny Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $735K | Buy |
1,308
+13
| +1% | +$8.34K | ﹤0.01% | 2202 |
|
|
2025
Q4 | $876K | Sell |
1,295
-1,920
| -60% | -$1.31M | ﹤0.01% | 2257 |
|
|
2025
Q3 | $2.05M | Buy |
+3,215
| New | +$1.95M | ﹤0.01% | 1777 |
|
|
2025
Q2 | – | Sell |
-1,525
| Closed | -$640K | – | 3065 |
|
|
2025
Q1 | $640K | Sell |
1,525
-930
| -38% | -$404K | ﹤0.01% | 2183 |
|
|
2024
Q4 | $1.01M | Buy |
2,455
+1,712
| +230% | +$751K | ﹤0.01% | 1943 |
|
|
2024
Q3 | $375K | Sell |
743
-284
| -28% | -$138K | ﹤0.01% | 2386 |
|
|
2024
Q2 | $500K | Sell |
1,027
-3,047
| -75% | -$1.53M | ﹤0.01% | 2057 |
|
|
2024
Q1 | $2.2M | Buy |
4,074
+3,081
| +310% | +$1.68M | ﹤0.01% | 1518 |
|
|
2023
Q4 | $551K | Sell |
993
-748
| -43% | -$351K | ﹤0.01% | 1914 |
|
|
2023
Q3 | $761K | Sell |
1,741
-1,758
| -50% | -$877K | ﹤0.01% | 1633 |
|
|
2023
Q2 | $1.76M | Sell |
3,499
-1,212
| -26% | -$581K | ﹤0.01% | 1421 |
|
|
2023
Q1 | $2.36M | Buy |
+4,711
| New | +$2.25M | 0.01% | 1393 |
|
|
2022
Q3 | – | Sell |
-3,455
| Closed | -$1.21M | – | 3027 |
|
|
2022
Q2 | $1.21M | Sell |
3,455
-17,529
| -84% | -$7.15M | ﹤0.01% | 1677 |
|
|
2022
Q1 | $11.5M | Buy |
+20,984
| New | +$11M | 0.04% | 648 |
|
|
2021
Q1 | – | Sell |
-18,453
| Closed | -$9.22M | – | 1905 |
|
|
2020
Q4 | $9.22M | Buy |
+18,453
| New | +$8.26M | 0.05% | 452 |
|
|
2019
Q4 | – | Sell |
-20,591
| Closed | -$5.6M | – | 1315 |
|
|
2019
Q3 | $5.6M | Buy |
20,591
+18,893
| +1,113% | +$5.26M | 0.04% | 525 |
|
|
2019
Q2 | $468K | Sell |
1,698
-6,716
| -80% | -$1.65M | ﹤0.01% | 1247 |
|
|
2019
Q1 | $1.88M | Sell |
8,414
-33,673
| -80% | -$6.95M | 0.01% | 840 |
|
|
2018
Q4 | $7.83M | Buy |
42,087
+32,883
| +357% | +$6.74M | 0.06% | 410 |
|
|
2018
Q3 | $2.3M | Buy |
9,204
+714
| +8% | +$173K | 0.01% | 935 |
|
|
2018
Q2 | $1.85M | Buy |
+8,490
| New | +$1.75M | 0.01% | 957 |
|
|
2018
Q1 | – | Sell |
-34,764
| Closed | -$5.44M | – | 2107 |
|
|
2017
Q4 | $5.44M | Buy |
34,764
+25,328
| +268% | +$3.99M | 0.02% | 829 |
|
|
2017
Q3 | $1.47M | Buy |
9,436
+4,725
| +100% | +$747K | 0.01% | 1051 |
|
|
2017
Q2 | $760K | Buy |
+4,711
| New | +$765K | ﹤0.01% | 1167 |
|
|
2017
Q1 | – | Sell |
-8,538
| Closed | -$1M | – | 1675 |
|
|
2016
Q4 | $1M | Buy |
+8,538
| New | +$974K | 0.01% | 1025 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$360K | – | 1381 |
|
|
2015
Q4 | $365K | Sell |
5,000
-280,958
| -98% | -$20M | ﹤0.01% | 911 |
|
|
2015
Q3 | $21.2M | Buy |
285,958
+149,704
| +110% | +$10.7M | 0.16% | 176 |
|
|
2015
Q2 | $8.74M | Buy |
+136,254
| New | +$9.43M | 0.05% | 435 |
|
Other funds holding IDXX
VCM
VPM
Balyasny Asset Management's IDXX Position: Q1 2026 in Review
Balyasny Asset Management increased its Idexx Laboratories (IDXX) stake by 1% in Q1 2026, buying an estimated $8.34K and bringing the position to 1,308 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #2202.
Balyasny Asset Management first reported a position in IDXX in Q2 2015 and has held it in 28 quarters since. The position peaked at $21.2M in Q3 2015. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Balyasny Asset Management held 1,308 shares of Idexx Laboratories worth $735K as of Q1 2026.
- Balyasny Asset Management bought 13 Idexx Laboratories shares in Q1 2026, an estimated $8.34K.
- Idexx Laboratories made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2202 holding.
- Balyasny Asset Management first reported a position in Idexx Laboratories in Q2 2015 and has held it in 28 quarters since.
- Balyasny Asset Management's Idexx Laboratories position peaked at $21.2M in Q3 2015.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.